Antineoplastic agents | Tenderlake

Antineoplastic agents

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
23 August 2023
Closing Date:
19 September 2023
Location(s):
PL426 Koszaliński (PL Poland/POLSKA)
Description:
Oncological drugs, software (II)

The subject of the contract is the supply of oncological drugs, including drugs from drug programs

Abirateroni acetas

Abirateroni acetas tabl. powl., 500 mg x 60 pcs. 200 op.

Venetoclaxum

1 Venetoclaxum, tabl. powl., 10 mg x 14 tabl. 15 on.

2 Venetoclaxum, tabl. powl., 50 mg x 7 tabl. 15 on.

3 Venetoclaxum, tabl. powl., 100 mg x 7 tabl. 15 on.

4 Venetoclaxum, tabl. powl., 100 mg x 14 tabl. 15 on.

5 Venetoclaxum, tabl. powl., 100 mg x 112 tabl. 200 on.

Tucatinibum

1 Tucatinibum 150 mg x 84 pcs. 100 op.

2 Tucatinibum 50 mg x 88 pcs. 20 op.

Larotrectinibum

1 Larotrectinibum 100 mg x 56 caps. 60 op.

2 Larotrectinibum 25 mg x 56 caps. 20 op.

Trabectedinum

1 Trabectedinum powder for concentrate for solution for infusion, 0.25 mg 40 op.

2 Trabectedinum powder for concentrate for solution for infusion, 1 mg 60 op.

CEMIPLIMABUM

Cemiplimabum concentrate for solution for infusion vial. 350 mg 30 pcs.

Download full details as .pdf
The Buyer:
Szpital Wojewódzki im. Mikołaja Kopernika
CPV Code(s):
33652100 - Antineoplastic agents